Posts
Today the U.S. Food and Drug
Administration (FDA) announced it has approved the drug combination of 300 mg
tenofovir and 200 mg emtricitabine (TDF/FTC; brand name Truvada) for daily use
by uninfected adults to help prevent the sexual acquisition of HIV.
TDF/FTC has
been commercially available as an HIV treatment since 2004. This is the first
time any drugs have been approved for the prevention of sexually acquired HIV
infection.
The Friends of AIDS Foundation is
dedicated to enhancing the quality of life for HIV positive individuals and
empowering people to make healthy choices to prevent the spread of the HIV
virus. To learn more about The Friends of AIDS Foundation, please visit: http://www.friendsofaids.org.
TOGETHER WE REMAIN STRONG!
